Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). (Q33346348)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). |
scientific article |
Statements
1 reference
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). (English)
1 reference
V Catalano
1 reference
S Barni
1 reference
F Ferraù
1 reference
G D Beretta
1 reference
L Frontini
1 reference
P Foa
1 reference
G Pancera
1 reference
D Priolo
1 reference
F Graziano
1 reference
M Mare
1 reference
G Catalano
1 reference
1 February 2003
1 reference
1 reference
14
1 reference
205-208
1 reference
Identifiers
1 reference
1 reference